List of bibliographic references
Number of relevant bibliographic references: 73.
[20-40] [
0 - 20][
0 - 50][
40-60]
| Ident. | Authors (with country if any) | Title |
|---|
| 000309 (2003) |
| Research Abstract Program of the 21st Annual ACVIM Forum Charlotte, NC, June 4–7, 2003 |
| 000326 (2002) |
Kanchan Anand [Allemagne] ; Gottfried J. Palm [Allemagne] ; Jeroen R. Mesters [Allemagne] ; Stuart G. Siddell [Allemagne] ; John Ziebuhr [Allemagne] ; Rolf Hilgenfeld [Allemagne] | Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α‐helical domain |
| 000333 (2001) |
Bert A. Hart [Pays-Bas] ; Herbert P. M Brok [Pays-Bas] ; Sandra Amor [Pays-Bas] ; Ronald E. Bontrop [Pays-Bas] | The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels |
| 000357 (2000) |
Per Klemm [Danemark] ; Mark A. Schembri [Danemark] | Fimbriae assisted bacterial surface display of heterologous peptides |
| 000365 (1999) |
Douglas S. Zatechka Jr. [États-Unis] ; Nagendra R. Hegde [États-Unis] ; Kandasamy Hariharan [États-Unis] ; S. Srikumaran [États-Unis] | Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1 |
| 000367 (1999) |
Dhammika S. Jayawardene [États-Unis] ; Chhabil Dass [États-Unis] | The effect of N-terminal acetylation and the inhibition activity of acetylated enkephalins on the aminopeptidase M-catalyzed hydrolysis of enkephalins☆ |
| 000384 (1998) |
Per Johan Klasse [Royaume-Uni] ; Romke Bron [Royaume-Uni] ; Mark Marsh [Royaume-Uni] | Mechanisms of enveloped virus entry into animal cells |
| 000390 (1998) |
John Lubinski [États-Unis] ; Thandavarayan Nagashunmugam [États-Unis] ; Harvey M. Friedman [États-Unis] | Viral interference with antibody and complement |
| 000437 (1995) |
Kai W. Wucherpfennig [États-Unis] ; Jack L. Strominger [États-Unis] | Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein |
| 000453 (1995) |
M. L. Akyürek [Suède] ; A. Wanders [Suède] ; M. Aurivillius [Suède] ; E. Larsson [Suède] ; K. Funa [Suède] ; B. C. Fellström [Suède] | Effects of angiopeptin on transplant arteriosclerosis in the rat |
| 000459 (1994) |
Gerald J. Chader [États-Unis] | Retinal degenerations of hereditary, viral and autoimmune origins: Studies on opsin and IRBP |
| 000464 (1994) |
Benjamin M. Segal [États-Unis] ; Cedric S. Raine [États-Unis] ; Dale E. Mcfarlin [États-Unis] ; Rhonda R. Voskuhl [États-Unis] ; Henry F. Mcfarland [États-Unis] | Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination |
| 000482 (1993) |
| Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy |
| 000486 (1993) |
| Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle |
| 000488 (1993) |
| Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis |
| 000489 (1993) |
| Patent bibliography |
| 000491 (1993) |
| New nucleic acid encoding E2 protein of canine corona virus; dog corona virus recombinant E2 protein production; may be used in recombinant vaccine production |
| 000492 (1993) |
| Induction of immunological response to mammal pathogen; rabies virus, cattle leukaemia virus, cat leukaemia virus or herpes simplex virus antigen gene cloning in an avipox virus vector for use as a recombinant vaccine |
| 000497 (1993) |
| Workshop P: Neuroimmunology |
| 000527 (1992) |
| Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
| 000528 (1992) |
| Vaccine comprising anti-idiotype antibody conjugate; induces production of neutralizing antibody (human monoclonal antibody, chimeric antibody or FAb, F(Ab′) 2 or Fv fragment) against HIV virus-1 |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Peptide"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i \
-Sk "Peptide" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Istex
|étape= Checkpoint
|type= indexItem
|index= Teeft.i
|clé= Peptide
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021 |  |
